66
Views
15
CrossRef citations to date
0
Altmetric
Review

Use of nanotechnology for the development of novel cancer biomarkers

&
Pages 679-683 | Published online: 09 Jan 2014

References

  • Segal NH, Pavlidis P, Antonescu CR et al. Classification and subtype prediction of adult soft tissue sarcoma by functional genomics. Am. J. Pathol.163(2), 691–700 (2003).
  • Chou WH, Yan FX, Robbins-Weilert DK et al. Comparison of two CYP2D6 genotyping methods and assessment of genotype–phenotype relationships. Clin. Chem.49(4), 542–551 (2003).
  • Ferrari M, Stenirri S, Bonini P, Cremonesi L. Molecular diagnostics by microelectronic microchips. Clin. Chem. Lab. Med.41(4), 462–467 (2003).
  • Borsting C, Sanchez JJ, Morling N. Multiplex PCR, amplicon size and hybridization efficiency on the NanoChip electronic microarray. Int. J. Leg. Med.118(2), 75–82 (2004).
  • Dyrskjot L. Classification of bladder cancer by microarray expression profiling: towards a general clinical use of micoarrays in cancer diagnostics. Exp. Rev. Mol. Diagn.3(5), 635–647 (2003).
  • Van’t Veer LJ, Dai H, van de Vijver MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature415(6871), 530–536 (2002).
  • Workman P. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies and molecular chaperones. Cancer Chemother. Pharmacol.52(Suppl. 1), 45–56 (2003).
  • Jez JM, Chen JC, Rastelli G, Stroud RM, Santi DV. Crystal structure and molecular modeling of 17-DMAG in complex with human Hsp90. Chem. Biol.10(4), 361–368 (2003).
  • Staudt LM. Molecular diagnosis of the hematologic cancers. N. Engl. J. Med.348(18), 1777–1785 (2003).
  • Koopmann J, Zhang Z, White N et al. Serum diagnosis of pancreatic adenocarinoma using surface-enhanced laser desorption and ionization mass spectrometry. Clin. Cancer Res.10(3), 860–868 (2004).
  • Cooksey RC, Limor J, Morlock GP, Crawford JT. Identifying Mycobacterium species and strain typing using a microfluidic labchip instrument. Biotechniques35(4), 786–794 (2003).
  • Jain KK. Nanodiagnostics: application of nanotechnology in molecular diagnostics. Exp. Rev. Mol. Diagn.3(2), 153–161 (2003).
  • Madoz-Gurpide J, Hanash SM. Molecular analysis of cancer using DNA and protein microarrays. Adv. Exp. Med. Biol.532, 51–58 (2003).
  • Kohlmann A, Schoch C, Schnittger S et al. Molecular characterization of acute leukemias by use of microarray technology. Genes Chromosomes Cancer37(4), 396–405 (2003).
  • Pirollo KF, Dagata J,Wang P et al. A tumor targeted nanodelivery system to improve early MRI detection of cancer. Mol. Imaging5(1), 41–52 (2006).
  • Leary SP, Liu CY, Apuzzo ML. Toward the emergence of nanoneurosurgery: part II – nanomedicine: diagnostics and imaging at the nanoscale level. Neurosurgery58(5), 805–823 (2006).
  • Park W, Owens JM. Future directions in the treatment of oral cancer. Otolaryngol. Clin. North Am.39(2), 381–396 (2006).
  • Manyak MJ, Jayitt M, Kang PS, Kreuger WR, Storm ES. The evolution of imaging in advanced prostate cancer. Urol. Clin. North Am.33(2), 133–146 (2006).
  • Wiestner A, Rosenwald A, Barry TS et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood101(12), 4944–4951 (2003).
  • Cheok MH, Yang W, Pui CH et al. Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells. Nat. Genet.34, 85–90 (2003).
  • Nishizuka S, Charboneau L, Young L et al. Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays. Proc. Natl Acad. Sci. USA100(24), 14229–14234 (2003).
  • Wulfkuhle JD, Aquino JA, Calvert VS et al. Signal pathway profiling of ovarian cancer from human tissue specimens using reverse-phase protein microarrays. Proteomics3(11), 2085–2090 (2003).
  • Banerjee H, Hawkins Z,Williams J et al. Search for a novel biomarker for the brain cancer Astrocytoma by using surface enhanced laser desorption/ionization (SELDI) technique. Cell. Mol. Bio.50(6), 733–736 (2004).
  • Sigurdsson S, Philipsen PA, Hansen LK, Larsen J, Gniadecka M, Wulf HC. Detection of skin cancer by classification of Raman spectra. IEEE Trans. Biomed. Eng.51(10), 1784–1793 (2004).
  • Chang YR, Hsu L, Chi S. Optical trapping of a spherically symmetric sphere in the ray-optics regime: a model for optical tweezers upon cells. Appl. Opt.45(16), 3885–3892 (2006).

Websites

  • The eSensor™ Biochip, Motorola Life Sciences, Pasadena, CA, USA. www.motorola.com/lifesciences/esencor/products_biochips.html

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.